ABSTRACT. Repetitive polysomnograms were recorded from a total of 33 infants, 19 healthy preterm infants, and 14 term controls between 40 wk postconceptional age and 6 mo of age. These nighttime recordings lasted 2-4 h, except at 52 wk in preterm infants and at 3 mo of age in term infants when an overnight 12-h recording was per With the onset of pulmonary ventilation after birth, arterial Po, levels rapidly rise from the 2.7-4.1 kPa (20-30 torr) characteristic of the fetus to approximately 8.1-9.5 kPa (60-70 torr), but Pco, levels do not change dramatically (1). During the first weeks of life, PCO, sensitivity increases slowly and P C O~ threshold decreases with age as evidenced by a displacement of the PCO,
response curve and a change in its slope (2) . The best documented example of change with age is probably the immature biphasic response to hypoxia, in which an initial increase in ventilation is followed almost immediately by a decrease to lower than baseline levels. This contrasts with the more mature pattern attained before 1 mo of age, when the infant manages to sustain an increase in ventilation throughout the hypoxic challenge (3, 4) .
With the advent of transcutaneous monitoring, a noninvasive tool to follow normal changes in Po, and Pco2 during the first months of life became available (5) . This technique has been successfully used to measure Po2 in the fetus and newborn (6) (7) (8) (9) and in older infants (10) (11) (12) (13) (14) (15) (16) (17) . Fewer studies have thus far dealt with Ptcco2 in term and preterm infants (1 0, 1 1, 18) . None of the studies of either Ptco2 or Ptcco2 used computer analysis of longitudinal polygraphic data. The present report describes postnatal changes in Ptco2 and Ptcco, thus obtained in preterm infants and healthy term control infants during the first 6 mo of life. The modulating effect of sleep and waking states was an integral part of the analysis.
MATERIALS AND METHODS
Material and monitoringprocedure. Fourteen normal subjects were selected during the last trimester of pregnancy, for study after birth, based on the absence of disease in their mothers. This group consisted of nine females and five males.
In addition, 19 appropriate-for-gestational-age preterm infants were selected in the nursery when they were between 32 and 36 wk PCA. Infants were excluded if they had received assisted ventilation for more than 24 h or supplemental oxygen for more than 48 h except for treatment of apnea. All medical conditions such as intracranial hemorrhage of grades 111 and IV and culture proven sepsis were also excluded. This preterm group consisted of five females and 14 males. Of these, nine exhibited two or more episodes of apnea > 20 s during an 8-h period beyond the first week of life. Because Ptco, and Ptcco2 were not significantly different upon follow-up, irrespective of the presence of previous apneic episodes, the data from these preterm infants reported in detail elsewhere (19) were combined and included here for comparison with those of term infants.
Our protocol was approved by the Los Angeles County/University of Southern California Medical Center Human Research Committee, and informed consent was obtained before each session. The study design called for repetitive laboratory monitoring after discharge from the hospital at 40, 44, and 52 wk PCA for the preterm group, and at 1, 3, and 6 mo of age for the term groups. Eighteen preterm infants returned to the sleep laboratory at 40 wk PCA, and 17 returned at 44 wk PCA. Only 10 parents were willing to return the infants for laboratory monitoring at 52 wk of age. For the controls the polygraphic recording schedule was adhered to. 74 HOPPENBROL Each infant was admitted to the sleep laboratory between 1700 and 1800 h for 2-to 4-h recordings, except at 3 mo or 52 wk, when 22 infants were monitored for 10-12 h overnight. The session began with a short physical and neurologic evaluation. The infants were fed during preparation for monitoring and application of electrodes, whereafter a demand feeding schedule was followed. Occasionally during an overnight recording the infant was breast-fed. Arm restraints were applied before the initiation of recording. Monitoring was camed out in a darkened room adjacent to the room containing the recording equipment. Although room temperatures ranged between 19.3 and 26.4"C, infants in each group were exposed to comparable temperatures, with the group means ranging between 2 1 and 22°C. The infants were placed in a supine or side-lying position and observed continuously with the help of a low-illumination television camera and monitor. Activities such as closing and opening of the eyes, startles, crying, and nursing interventions were charted on the polygraph paper (20) .
Physiologic recording methods. Sleep variables included two EEG derivations (approximately C 1 -C5 and C2-C6, according to the International 10-20 system), a chin electromyogram, and eye movements. Electrodes on the mattress surface under the crib sheet registered the infant's body movements. Thoracic and abdominal excursions were monitored by strain gages, and a Pco2 monitor (Beckman Instruments, Inc., Palo Alto, CA) sampled expired gas through a miniature cannula taped under the infant's nostrils. The ECG was recorded with two disposable electrodes placed beneath the clavicles. Additionally, a skin temperature probe was applied to the abdomen below the right costal margin (20) .
Ptco2 and Ptcco2 were measured with a Novametrix (Wallingford, CT) monitor. The O2 and C02 electrodes were taped to the right and left upper chest, respectively. An O2 electrode temperature of 43.5"C was selected, and during a 12-h recording the electrode placement was altered by several millimeters at 4-to 6-h intervals. The C 0 2 electrode was unheated. Both electrodes were calibrated at the onset and termination of each monitoring session or at 4-to 6-h intervals with gases of known 0 2 and C 0 2 concentration [0 and 12.4 kPa (92 mm Hg) for 02; 5.1 and 10.3 kPa (38 and 76 mm Hg) for C02]. Humidity of the room air was sampled on an hourly basis during the monitoring and was comparable in each study group.
The data were recorded on a 16-channel model 76 polygraph (Grass Instrument Co., Quincy, MA) at 6 mm/s paper speed and on an eight-channel Brush recorder (Gould, Inc., Cleveland, OH) at 1 cm/min paper speed and stored simultaneously with a time code on a 14-channel analog tape recorder (Honeywell Inc., Van Nuys, CA).
Data analysis. The polygraphic tracings were coded by trained observers into minutes of AS, QS, AW, and indeterminate sleep, according to generally accepted criteria described elsewhere (2 1). Every 50th min of the recording was recoded by an independent observer to ensure an agreement between coders of at least 80%. Minutes of indeterminate sleep were not further used for analysis because of low interrater reliability.
Data on the analog tapes were digitized by a preprocessing microcomputer with eight channels of analog to digital interface (22) . The sampling rate was 11s for Ptco2 and Ptcco2. Several steps were taken to reduce contamination of the data by artifact: First, each minute of the computer output was scanned for abnormal values with the polygraphic recording used as an ultimate reference. Second, the magnitude of the electrode drift was measured by comparing initial and end calibrations. If the drift between the onset and end calibrations equalled or exceeded 0.68 kPa (5 mm Hg), the minute by minute values were adjusted by the formula m(adj) = m -(a + bm)t (see Appendix). This formula assumes that the drift is linear, an assumption that did not bias the data in favor of any of the sleep state, study, or age groups. The Ptccol values were further adjusted by the formula Ptcco2 = 1.14 arterial Pco2 + 4.88, to better reflect arterial values (23).
Sleep state classifications were then integrated with the computer data and together plotted on a minute by minute basis (Fig. 1) . In addition, a 10-min moving average was generated to better allow visualization of the interrelationship between variables ( Fig. 2) . For every minute, the number of times the Ptco2 was two SD lower than the mean for that minute was also determined. For Ptcco, the same value was calculated as well as the times the Ptcco2 reached two SD above the mean. The tracings were also scanned visually for the presence of transient decreases in Ptco2 in excess of 2.03 kPa (15 mm Hg). Because the Ptco2 signal varies widely during wakefulness, this analysis was restricted to periods when the infant was asleep. Computergenerated minute by minute mean values of Ptcco2 levels in excess of 6.75 kPa (50 ton) were identified for each infant and each sleep state as well.
The means of all the minute to minute data of Ptc02 and Ptcco2 levels and variability were obtained for each infant, and the data were compared as a function of study group, age, and sleep state, with the aid of an analysis of variance (BMD P4V) or a t test (24).
RESULTS

Clinicalfindings.
Clinical characteristics are provided in Table  1 . The controls were of low obstetric risk with only one complication: a prolonged second stage labor. There was a higher incidence of complications in the mothers of preterm infants, as would be expected, with seven of 19 exhibiting such problems as preeclampsia and amnionitis. All infants were appropriate for gestational age, in good condition at birth, and few had nursery complications. The preterm group was specifically selected for absence of neonatal problems.
On follow-up of control infants, abnormal physical findings were limited to transient neurologic abnormalities and sporadic evidence of upper respiratory infections. Approximately half of the prematures were readmitted to the hospital after nursery discharge, usually for treatment of infection. When last seen, growth was normal in infants of both study groups. With one exception in the preterm apneic group, all infants exhibited normal developmental progress as well.
Sleep and waking. Monitoring of Ptc02 requires repositioning of the heated electrode and precludes undisturbed sleep during the night. Therefore, the overnight tracings were not suited to ascertain the presence of detailed sleep and wakefulness differences between infants. For the same reason, they were unsuited to reveal a circadian modulation of Ptco2 and Ptcco2 levels in the 3-mo-old and 52-wk-old infants' overnight recordings.
As reported elsewhere (1 9), the amounts of sleep and waking in preterm infants with and without apnea in the nursery could with one exception not be differentiated. The exception was found at 44 wk in the preterm group, where the infants who had experienced prolonged apnea in the neonatal period had more AS and fewer awakenings than the preterm infants who had not experienced apnea. There were no other significant differences in the percentages of QS, AS, and AW between control and preterm infants at their corrected ages (Table 2) .
Transcutaneous gases. A representative sample of the transcutaneous tracings shows variations in Ptco2 and Ptcc02 on a minute by minute basis (Fig. 3) .
Comparison of preterm and term control infants. When the values of the total preterm group at 44 and 52 wk PCA were compared with those of the term control group at the comparable ages of 1 and 3 mo, no differences were observed in the level and variability of either Ptco, or Ptcc02 (Table 3) .
Ptcco2 levels in excess of 6.75 kPa (50 ton) were seen in 35, 29, and 9% of the preterm infants at 40, 44, and 52 wk, respectively. Comparable values for the term control group were 33, 10, and 7.6% at 1, 3, and 6 mo. Transcutaneous gases as function of age. 1n preterm infants a Transient drops in Ptco2 as measured by deviations in excess significant age effect in Ptc02 level was observed in all states (QS: of two SD from the mean for that minute occurred on the F = 8.78, df 2,5, P < 0.03; AS: F = 88.76, df 2,5, P < 0.0001; average between 1.0 and 1.3 times per min at every age in both AW: F = 9.16, df 2,5, P < 0.03). This represents a rise in Ptco2 preterm and term control infants. The range of such events per level between 40 and 52 wk in these infants (Fig. 4) . A significant min varied between 0 and 8 in preterm infants but could be as age effect was also observed when the two groups were combined high as in term control infants. There was no correlation (F = 6.64, df 1,26, p < 0.02). The rise in Ptco2 levels with age was seen in every state, including AW ( ' .LA;;.
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--- at any age (Table 3 ). The variability of Ptco2 showed a significant state effect as well ( F = 29.29, d f 3 , 5 , p < 0.001). The highest infants at 40 wk (range 1-16), 38% at 44 wk (range 1-4), and variability was seen during AW, followed by that of AS and then 9% of the infants at 52 wk (only one infant with one decrease). QS (Table 3 ). The maximum number of relative drops, however,
In term control infants, such decreases were observed in 29% of and the absolute decreases in Ptc02 exhibited no preference for infants at 1 mo (range 1-2), 7% at 3 mo (only one infant with any sleep state. one decrease), and none at 6 mo. Thus, at comparable ages, there Ptcco, levels were elevated in QS compared to AS at all ages were no differences between term control and preterm infants. and in both study groups. As with Ptco2 variability, the variability The rise in Ptco, was accompanied by a significant decline in of Ptcco2 was significantly higher during AS compared to QS. mean Ptccoz levels during the first 3 mo of life, again in all states There was no one state in the term infant in which hypercapnic (AS: p < 0.05; QS: p < 0.05; AW: p < 0.02). This decline, values occurred more frequently. In the preterm group at 40 wk, however, was only significant in term babies.
however, more than half (56%) of the infants' mean Ptcco2 levels Ptcco2 variability did not change as a function of age, nor did during QS reached what are considered hypercapnic values. 
DISCUSSION
Computer analysis of systematically obtained polygraphic data revealed an increase in Ptco2 levels between 40 wk and 3 mo of age, coupled with a simultaneous decline in Ptcco2 levels. At the same conceptional age, preterm infants exhibited similar levels of both Ptco2 and Ptcco2 as term control. Although wakefulness induced Ptco2 levels higher than those in sleep, no differences were seen in levels of Ptco2 during AS and QS. Variability of Ptco2, however, was invariably higher during AS than QS. In contrast, a sleep state modulation of both the level and variability of Ptcco2 was observed at every age. Ptcco2 levels were higher during QS and the variability lower.
The values for the levels of Ptco2 are quite comparable to those obtained by others (6, (10) (11) (12) (13) 16) During sleep, decreases in Rco2 in excess of 2.0 kPa (1 5 mm Hg) declined with age. They were observed in about one third of the youngest control infants and in less than 10% of the 3-moold infants and were absent at 6 mo. The fact that during wakefulness such variations are so abundant implies that these drops are generally benign. The similarity in the incidence of these P~C O Z drops between term control infants and preterm infants is striking at corrected ages. This finding parallels the similarity in levels of Ptco2 at corrected ages in these two groups.
Ptcco2 was measured with an unheated electrode, a state-ofthe-art technique when we collected our data that is not currently being used clinically. The resultant data are unique because undisturbed skin Pco2 is provided; local heating has not altered local metabolism nor increased Pco2 production. In our normal healthy infants, comparison with arterial values was not warranted. Such a study was, however, performed previously and had yielded a correlation coeficient comparable to those obtained by others (18, 23, 25 In preterm and term infants during the first week of life, Hanson and Okken (6) reported a higher level of Ptco2 in QS than in AS. In our study, where the infants were at least 4 wk old, differences of Ptco2 during various states were restricted to variability and were not seen in levels. It is almost certain that these differences in findings are attributable to maturation, because Mok et al. (1 3) reported that the level of Ptco2 in QS was higher than in AS in their youngest group, a difference that disappeared after the first week of life. Lastly, Martin et a/. (1 8) reported higher Ptcco2 levels in QS than in AS in term newborns, a difference that persisted until 6 mo according to our data. Thus, state differences in Ptco2 continue in older infants, whereas those in Ptco2 seem to disappear early. Considerable evidence has been accumulating that breathing regulation in AS is not the same as that in QS (1, 2) . A lowered Ptcco2 in AS indicates an increase in alveolar ventilation. In contrast, QS is characterized by a relative hypoventilation and an increased PCO~ threshold (1 8).
It is generally assumed that after neonatal adjustment, the infant's chemoreceptor reflexes are stable. However, transcutaneously measured Po2 continues to rise between 1 and 3 mo in both term and preterm infants. This rise occurs despite the thickening of the skin (13) . It may be a result of improved matching of ventilation and perfusion due to a more stable rib cage (1 I), or it may be due to lung development (26). The rise represents an even larger increase in arterial values because in older infants Ptco2 increasingly underestimates arterial 0 2 tension (27).
In our study the Ptcco2 declined between 1 and 3 mo of age in term infants, a finding not reported before. Hazinski et al.
(28) found a continued adjustment of chemoreceptor function during the first 2 mo of life in preterm infants before nursery discharge. Bryan (29) recently described a clear increase with age of the ventilatory response to P C O~ in normal term controls and siblings of infants with sudden infant death syndrome. Therefore, our data supports the idea that adjustments in the chemoreceptor system continue to take place beyond the first weeks of life.
In conclusion, few differences were found between term and preterm infants when corrected for gestational age. Ptcco2 but not Ptco2 levels were modulated by sleep and wakefulness, with P~C C O~ being higher in QS than in AS. The most important findings were the evidence for continued regulatory changes in ventilatory control during the first 3 mo of life. These changes include a rise in levels of Rco2, a reduction in levels of Ptcco,, decreased variability of Ptco2 in term infants, and a decline in the number of drops exceeding 2.03 kPa (15 mm Hg), all suggesting increased stability of the system. Finally, a surprising number of hypercapnic values were seen in the youngest group, especially during QS, and these disappeared with increasing age.
